| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
Dimethylfumarate inhibits angiogenesis in vitro and in vivo: a possible role for its antipsoriatic effect?
|
J Invest Dermatol
|
2011
|
1.90
|
|
2
|
Anti-angiogenic and anti-inflammatory properties of kahweol, a coffee diterpene.
|
PLoS One
|
2011
|
1.11
|
|
3
|
Antiangiogenic activity of aeroplysinin-1, a brominated compound isolated from a marine sponge.
|
FASEB J
|
2001
|
1.07
|
|
4
|
Hyperforin, a bio-active compound of St. John's Wort, is a new inhibitor of angiogenesis targeting several key steps of the process.
|
Int J Cancer
|
2005
|
1.06
|
|
5
|
Study of puupehenone and related compounds as inhibitors of angiogenesis.
|
Int J Cancer
|
2004
|
1.02
|
|
6
|
Challenges of antiangiogenic cancer therapy: trials and errors, and renewed hope.
|
J Cell Mol Med
|
2007
|
1.00
|
|
7
|
Hyperforin: more than an antidepressant bioactive compound?
|
Life Sci
|
2006
|
0.96
|
|
8
|
Anti-angiogenic properties of carnosol and carnosic acid, two major dietary compounds from rosemary.
|
Eur J Nutr
|
2011
|
0.91
|
|
9
|
Effects of ursolic acid on different steps of the angiogenic process.
|
Biochem Biophys Res Commun
|
2004
|
0.90
|
|
10
|
Hypericin in the dark inhibits key steps of angiogenesis in vitro.
|
Eur J Pharmacol
|
2005
|
0.89
|
|
11
|
Toluquinol, a marine fungus metabolite, is a new angiosuppresor that interferes with the Akt pathway.
|
Biochem Pharmacol
|
2013
|
0.89
|
|
12
|
The antiangiogenic compound aeroplysinin-1 induces apoptosis in endothelial cells by activating the mitochondrial pathway.
|
Mar Drugs
|
2012
|
0.83
|
|
13
|
Homocysteine is a potent inhibitor of human tumor cell gelatinases.
|
Biochem Biophys Res Commun
|
2003
|
0.81
|
|
14
|
4-methylumbelliferone inhibits angiogenesis in vitro and in vivo.
|
J Agric Food Chem
|
2013
|
0.81
|
|
15
|
What is known on angiogenesis-related rare diseases? A systematic review of literature.
|
J Cell Mol Med
|
2012
|
0.81
|
|
16
|
IB05204, a dichloropyridodithienotriazine, inhibits angiogenesis in vitro and in vivo.
|
Mol Cancer Ther
|
2007
|
0.80
|
|
17
|
The brominated compound aeroplysinin-1 inhibits proliferation and the expression of key pro- inflammatory molecules in human endothelial and monocyte cells.
|
PLoS One
|
2013
|
0.79
|
|
18
|
A modified chorioallantoic membrane assay allows for specific detection of endothelial apoptosis induced by antiangiogenic substances.
|
Angiogenesis
|
2003
|
0.78
|
|
19
|
The anti-angiogenic 8-epipuupehedione behaves as a potential anti-leukaemic compound against HL-60 cells.
|
J Cell Mol Med
|
2008
|
0.77
|
|
20
|
Synthesis and biological evaluation of epothilone A dimeric compounds.
|
Bioorg Med Chem
|
2009
|
0.77
|
|
21
|
An in vitro evaluation of the effects of homocysteine thiolactone on key steps of angiogenesis and tumor invasion.
|
Biochem Biophys Res Commun
|
2003
|
0.77
|
|
22
|
Exploring and challenging the network of angiogenesis.
|
Sci Rep
|
2011
|
0.77
|
|
23
|
Raman optical activity spectra and conformational elucidation of chiral drugs. The case of the antiangiogenic aeroplysinin-1.
|
J Phys Chem A
|
2011
|
0.77
|
|
24
|
DTD, an anti-inflammatory ditriazine, inhibits angiogenesis in vitro and in vivo.
|
J Cell Mol Med
|
2008
|
0.75
|
|
25
|
Tetrahydrohyperforin and octahydrohyperforin are two new potent inhibitors of angiogenesis.
|
PLoS One
|
2010
|
0.75
|